X4 PHARMACEUTICALS, INC Stock Issued During Period, Shares, Conversion of Convertible Securities
X4 PHARMACEUTICALS, INC (XFOR) reported Stock Issued During Period, Shares, Conversion of Convertible Securities of 7.18 million shares for the 0-month period ending 2017-11-20, per its 10-K filed 2019-03-11.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2019-03-11
- 2017-11-20: Stock Issued During Period, Shares, Conversion of Convertible Securities 0 month 7.18M shares; Stock Issued During Period, Shares, Conversion of Convertible Securities 7.18M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities 0 month | Stock Issued During Period, Shares, Conversion of Convertible Securities |
|---|---|---|
| 2017-11-20 | 7.18M shares 10-K · filed 2019-03-11 | 7.18M shares 10-Q · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |